Refractory Epilepsy
58
9
11
20
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.3%
6 terminated out of 58 trials
76.9%
-9.6% vs benchmark
9%
5 trials in Phase 3/4
15%
3 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (58)
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Optimal Stimulation Parameters to Disrupt Epileptiform Activity
Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
Characterising the Network-Specific Effects of Piriform Cortex Stimulation Via SEEG
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Investigating the Role and Electrophysiological Characteristics of the Human Claustrum Based on SEEG
Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
An Automated Navigation System for Deep Brain Electrode Implantation
Atlas of Human Cognition by SEEG (MAPCOG-SEEG)
Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy
Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation
Expanded Use of Cannabidiol Oral Solution